Shilpa Medicare: Shilpa'S Tranexamic Acid Spray (Hemostatic Spray) Is Approved By CDSCO (Dcgi) | Value Research

Shilpa Medicare: Shilpa'S Tranexamic Acid Spray (Hemostatic Spray) Is Approved By CDSCO (Dcgi)

Shilpa would like to announce its successful innovation of first in world topical hemostatic spray of Tranexamic Acid has received CDSCO approval. This novel formulation of spray is simple easy to carry convenient to use and a lifesaving tool. Clinically proven in humans and validated in robust swine trauma model. The product is approved for the usage of reducing or preventing hemorrhage and to reduce the need of replacement therapy during accidental and domestic injury.....

Click here to view PDF


Other Categories